1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Orphan Diseases Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Autoimmune Disorders
  • 1.2.3 Genetic Disorders
  • 1.2.4 Blood Disorders
  • 1.2.5 Cancer
  • 1.2.6 Growth Disorder
  • 1.2.7 Cardiovascular Diseases
  • 1.2.8 Neurological Disorders
  • 1.2.9 Respiratory Disorders
  • 1.2.10 Digestive Disorders
  • 1.2.11 Eye Disorders
• 1.3 Market by Application
  • 1.3.1 Global Orphan Diseases Market Share by Application: 2020 VS 2026
  • 1.3.2 Hospitals And Clinics
  • 1.3.3 Research Laboratories
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Orphan Diseases Market Perspective (2015-2026)
• 2.2 Global Orphan Diseases Growth Trends by Regions
  • 2.2.1 Orphan Diseases Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Orphan Diseases Historic Market Share by Regions (2015-2020)
  • 2.2.3 Orphan Diseases Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Orphan Diseases Players by Market Size
  • 3.1.1 Global Top Orphan Diseases Players by Revenue (2015-2020)
  • 3.1.2 Global Orphan Diseases Revenue Market Share by Players (2015-2020)
• 3.2 Global Orphan Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Orphan Diseases Revenue
• 3.4 Global Orphan Diseases Market Concentration Ratio
  • 3.4.1 Global Orphan Diseases Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Orphan Diseases Revenue in 2019
• 3.5 Key Players Orphan Diseases Area Served
• 3.6 Key Players Orphan Diseases Product Solution and Service
• 3.7 Date of Enter into Orphan Diseases Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Orphan Diseases Breakdown Data by Type (2015-2026)

• 4.1 Global Orphan Diseases Historic Market Size by Type (2015-2020)
• 4.2 Global Orphan Diseases Forecasted Market Size by Type (2021-2026)

5 Orphan Diseases Breakdown Data by Application (2015-2026)

• 5.1 Global Orphan Diseases Historic Market Size by Application (2015-2020)
• 5.2 Global Orphan Diseases Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Orphan Diseases Market Size (2015-2026)
• 6.2 North America Orphan Diseases Market Size by Type (2015-2020)
• 6.3 North America Orphan Diseases Market Size by Application (2015-2020)
• 6.4 North America Orphan Diseases Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Orphan Diseases Market Size (2015-2026)
• 7.2 Europe Orphan Diseases Market Size by Type (2015-2020)
• 7.3 Europe Orphan Diseases Market Size by Application (2015-2020)
• 7.4 Europe Orphan Diseases Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Orphan Diseases Market Size (2015-2026)
• 8.2 China Orphan Diseases Market Size by Type (2015-2020)
• 8.3 China Orphan Diseases Market Size by Application (2015-2020)
• 8.4 China Orphan Diseases Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Orphan Diseases Market Size (2015-2026)
• 9.2 Japan Orphan Diseases Market Size by Type (2015-2020)
• 9.3 Japan Orphan Diseases Market Size by Application (2015-2020)
• 9.4 Japan Orphan Diseases Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Orphan Diseases Market Size (2015-2026)
• 10.2 Southeast Asia Orphan Diseases Market Size by Type (2015-2020)
• 10.3 Southeast Asia Orphan Diseases Market Size by Application (2015-2020)
• 10.4 Southeast Asia Orphan Diseases Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Bristol-Myers Squibb
  • 11.1.1 Bristol-Myers Squibb Company Details
  • 11.1.2 Bristol-Myers Squibb Business Overview
  • 11.1.3 Bristol-Myers Squibb Orphan Diseases Introduction
  • 11.1.4 Bristol-Myers Squibb Revenue in Orphan Diseases Business (2015-2020))
  • 11.1.5 Bristol-Myers Squibb Recent Development
• 11.2 Novartis
  • 11.2.1 Novartis Company Details
  • 11.2.2 Novartis Business Overview
  • 11.2.3 Novartis Orphan Diseases Introduction
  • 11.2.4 Novartis Revenue in Orphan Diseases Business (2015-2020)
  • 11.2.5 Novartis Recent Development
• 11.3 Celgene
  • 11.3.1 Celgene Company Details
  • 11.3.2 Celgene Business Overview
  • 11.3.3 Celgene Orphan Diseases Introduction
  • 11.3.4 Celgene Revenue in Orphan Diseases Business (2015-2020)
  • 11.3.5 Celgene Recent Development
• 11.4 Roche
  • 11.4.1 Roche Company Details
  • 11.4.2 Roche Business Overview
  • 11.4.3 Roche Orphan Diseases Introduction
  • 11.4.4 Roche Revenue in Orphan Diseases Business (2015-2020)
  • 11.4.5 Roche Recent Development
• 11.5 Pfizer
  • 11.5.1 Pfizer Company Details
  • 11.5.2 Pfizer Business Overview
  • 11.5.3 Pfizer Orphan Diseases Introduction
  • 11.5.4 Pfizer Revenue in Orphan Diseases Business (2015-2020)
  • 11.5.5 Pfizer Recent Development
• 11.6 Alexion
  • 11.6.1 Alexion Company Details
  • 11.6.2 Alexion Business Overview
  • 11.6.3 Alexion Orphan Diseases Introduction
  • 11.6.4 Alexion Revenue in Orphan Diseases Business (2015-2020)
  • 11.6.5 Alexion Recent Development
• 11.7 Sanofi
  • 11.7.1 Sanofi Company Details
  • 11.7.2 Sanofi Business Overview
  • 11.7.3 Sanofi Orphan Diseases Introduction
  • 11.7.4 Sanofi Revenue in Orphan Diseases Business (2015-2020)
  • 11.7.5 Sanofi Recent Development
• 11.8 Vertex Pharmaceuticals
  • 11.8.1 Vertex Pharmaceuticals Company Details
  • 11.8.2 Vertex Pharmaceuticals Business Overview
  • 11.8.3 Vertex Pharmaceuticals Orphan Diseases Introduction
  • 11.8.4 Vertex Pharmaceuticals Revenue in Orphan Diseases Business (2015-2020)
  • 11.8.5 Vertex Pharmaceuticals Recent Development
• 11.9 GlaxoSmithKline
  • 11.9.1 GlaxoSmithKline Company Details
  • 11.9.2 GlaxoSmithKline Business Overview
  • 11.9.3 GlaxoSmithKline Orphan Diseases Introduction
  • 11.9.4 GlaxoSmithKline Revenue in Orphan Diseases Business (2015-2020)
  • 11.9.5 GlaxoSmithKline Recent Development
• 11.10 Merck
  • 11.10.1 Merck Company Details
  • 11.10.2 Merck Business Overview
  • 11.10.3 Merck Orphan Diseases Introduction
  • 11.10.4 Merck Revenue in Orphan Diseases Business (2015-2020)
  • 11.10.5 Merck Recent Development
• 11.11 Abbvie
  • 10.11.1 Abbvie Company Details
  • 10.11.2 Abbvie Business Overview
  • 10.11.3 Abbvie Orphan Diseases Introduction
  • 10.11.4 Abbvie Revenue in Orphan Diseases Business (2015-2020)
  • 10.11.5 Abbvie Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Orphan Diseases Scope and Market Size
Orphan Diseases market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Orphan Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Autoimmune Disorders
Genetic Disorders
Blood Disorders
Cancer
Growth Disorder
Cardiovascular Diseases
Neurological Disorders
Respiratory Disorders
Digestive Disorders
Eye Disorders

Market segment by Application, split into
Hospitals And Clinics
Research Laboratories

Based on regional and country-level analysis, the Orphan Diseases market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Orphan Diseases market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Bristol-Myers Squibb
Novartis
Celgene
Roche
Pfizer
Alexion
Sanofi
Vertex Pharmaceuticals
GlaxoSmithKline
Merck
Abbvie